IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,011,146 | +207.2% | 964,083 | +51.8% | 0.43% | +203.5% |
| Q2 2023 | $12,047,676 | +464.5% | 635,091 | +361.6% | 0.14% | +393.1% |
| Q1 2023 | $2,134,052 | -85.3% | 137,592 | -83.2% | 0.03% | -85.1% |
| Q4 2022 | $14,501,022 | +47.3% | 816,959 | -53.7% | 0.19% | +40.6% |
| Q3 2022 | $9,845,000 | +2642.3% | 1,764,290 | +1815.6% | 0.14% | +2200.0% |
| Q2 2022 | $359,000 | -82.9% | 92,100 | -61.9% | 0.01% | -82.4% |
| Q3 2021 | $2,099,000 | -94.7% | 241,599 | -93.6% | 0.03% | -95.4% |
| Q2 2021 | $39,644,000 | +175.7% | 3,750,575 | +318.3% | 0.74% | +131.7% |
| Q1 2021 | $14,382,000 | +3.1% | 896,617 | +197.0% | 0.32% | -13.8% |
| Q4 2020 | $13,945,000 | +180.7% | 301,903 | +113.9% | 0.37% | +127.0% |
| Q3 2020 | $4,968,000 | -11.6% | 141,170 | -38.9% | 0.16% | -26.9% |
| Q2 2020 | $5,623,000 | +11.1% | 230,908 | -29.0% | 0.22% | -38.4% |
| Q1 2020 | $5,061,000 | +17.2% | 325,183 | +19.3% | 0.36% | +104.5% |
| Q4 2019 | $4,320,000 | – | 272,539 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |